Find a Tender
complete
Official procurement procedure
High resolution, in situ platform to combine single-cell and spatial genomics analyses.
Medical equipments
Medical equipments
pharmaceuticals and personal care products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: THE UNIVERSITY OF MANCHESTER: "High resolution, in situ platform to combine single-cell and spatial genomics analyses.". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | THE UNIVERSITY OF MANCHESTER | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: THE UNIVERSITY OF MANCHESTER
Market Analytics
Derived from OCDS awards & bid statistics
Published history for THE UNIVERSITY OF MANCHESTER. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
8Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 5 active published awards; 4 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityTHE UNIVERSITY OF MANCHESTER | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published14 Jun 2023, 10:52 BST | Last source update14 Jun 2023, 10:52 BST | Recurring procurementNot published |
ClassificationMedical equipments, Medical equipments, pharmaceuticals and personal care products | ||
Delivery area | ||
OCIDocds-h6vhtk-03d602 | ||
What is being bought
The high resolution, in situ platform to combine single-cell and spatial genomics analyses, is required by the Genomic Technologies Core Facility (GTCF). Enabling multiplexed, error-robust, single-cell in situ transcriptomic imaging from whole tissue to subcellular resolution.
What changed
From the official release history
- Status changed to complete
14 Jun 2023, 10:52 BST - Official notice release published
14 Jun 2023, 10:52 BST - Buyer information updated
14 Jun 2023, 10:52 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedResearch - Genomic Technologies Core Facility (GTCF)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
14 Jun 2023, 10:52 BST - Award active
Not published · Not published - Contract active
Signed 8 Jun 2023, 00:00 BST · £428,000
Commercial outcome and competition
Awards Vizgen Inc. Not published · Not published · active |
Contracts High resolution, in situ platform to combine single-cell and spatial genomics analyses £428,000 · signed 8 Jun 2023, 00:00 BST · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
THE UNIVERSITY OF MANCHESTER
Contracting authority GB-COH-RC000797Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe High resolution in situ platform to combine single-cell and spatial genomics analyses, is required by the Genomic Technologies Core Facility
The High resolution in situ platform to combine single-cell and spatial genomics analyses is provided by Vizgen Inc., who are the sole provider of the MERSCOPE Platform. MERSCOPE is the
MERFISH technology platform solution developed by the supplier. The MERSCOPE Platform is powered by MERFISH (Multiplexed Error Robust in situ Hybridization) technology, which is exclusively licensed to Vizgen by Harvard University for commercialisation.
This solution enables multiplexed, error-robust, single-cell in situ transcriptomic imaging from whole tissue to subcellular resolution.
This product and it's use is covered by U.S. patents |